Point72 Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-857,853
| Closed | -$6.39M | – | 1441 |
|
|
2024
Q4 | $6.39M | Buy |
857,853
+406,535
| +90% | +$3.03M | 0.01% | 635 |
|
|
2024
Q3 | $3.61M | Sell |
451,318
-179,451
| -28% | -$1.43M | 0.01% | 656 |
|
|
2024
Q2 | $5.49M | Buy |
+630,769
| New | +$5.49M | 0.01% | 618 |
|
|
2024
Q1 | – | Sell |
-8,300
| Closed | -$192K | – | 1575 |
|
|
2023
Q4 | $192K | Buy |
+8,300
| New | +$192K | ﹤0.01% | 1131 |
|
|
2022
Q4 | – | Sell |
-490,200
| Closed | -$3.88M | – | 1197 |
|
|
2022
Q3 | $3.88M | Sell |
490,200
-729,499
| -60% | -$5.77M | 0.02% | 678 |
|
|
2022
Q2 | $9.6M | Buy |
1,219,699
+186,899
| +18% | +$1.47M | 0.04% | 461 |
|
|
2022
Q1 | $12.5M | Buy |
+1,032,800
| New | +$12.5M | 0.05% | 411 |
|